Momenta Seeks to Raise $57M to Fund Follow-on Biologics
By Marie Powers
Thursday, December 9, 2010
Just one day after filing a prospectus with the SEC for a registered underwritten public offering, Momenta Pharmaceuticals Inc. has priced the offering of 4 million shares of its common stock (NASDAQ:MNTA) at $14.35 per share. The proceeds, before expenses, to Momenta will be approximately $57.4 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.